Medtronic, India launches new generation Insulin Pump therapy for diabetes management
There is growing concern among city endocrinologists and diabetologists about the rising number of adolescents being diagnosed with diabetes in the city and in order to raise awareness and introduce new generation insulin pump therapy which help manage diabetes more accurately, India Medtronic organised a roundtable introducing ‘MiniMed Paradigm® VEO™’, the world’s first and only CGM-ready insulin pump with an automatic insulin shut-off mechanism.
The session began with a knowledge-sharing discussion on diabetes management with help of first generation Insulin Pump therapy by Dr Shashank Joshi, Consultant Endocrinologist, Lilavati and Bhatia Hospital which was later followed by a session on ‘Living a Complete Life with Diabetes’ by. Mari Ruddy, Founder, Team WILD who is a great inspiration for diabetes patients across the globe and is currently visiting India on her mission to raise awareness on diabetes management through insulin pump therapy.
Dr Joshi explaining the new generation insulin pump therapy said, “MiniMed Paradigm® VEO™ insulin pump can suspend insulin delivery when the device senses that glucose levels have fallen to or is below a user-selected threshold. This feature is intended to reduce the severity of low blood sugar (hypoglycemia) in situations where patients ignore or are unable to treat hypoglycemia. A dangerous and often frequent occurrence in diabetes management, hypoglycemia can be one of the most frightening aspects of living with type 1 diabetes. If left untreated, hypoglycemia can cause loss of consciousness, seizure, or coma.”
He further said, “The MiniMed Paradigm® VEO™ insulin pump is the first big step towards ‘closing the loop’ in diabetes management. This innovative and novel technology enables the detection of dangerously low glucose levels and can automatically suspend insulin delivery by the pump, thereby preventing a severe hypoglycemia event. Pump technology is a significant breakthrough in the therapeutic horizon of not only each and every Type 1 Diabetic, but also many of insulin-requiring Type 2 diabetics. Pregnant mothers having diabetes need such technology to optimise their diabetes control for a happy outcome. In hospital care of diabetics will also get a boost with the advent of such technology.”
Present on the occasion, Mari Ruddy who is also an athlete and a cancer survivor. Being a type-1 diabetes patient for 30 years and a two-time breast cancer survivor is on her mission to support and inspire women with type 1 diabetes. Ruddy survives on an insulin pump which has a convenient built in continuous glucose monitoring. This device helps her with protection from sudden sugar lows and highs. Through this therapy, she receives frequent updates on her glucose levels and early notices of oncoming lows and highs on her insulin pump screen which helps her maintain her daily glucose levels according to her lifestyle.
Ruddy talking to the media said, “I was diagnosed with type-1 diabetes when I was 16 years old. With a family history of diabetes, I was brought up in an environment that navigated a world of healthy eating, blood sugar management, and insulin injections. Since then, I have been living with this challenging disease. With the support and love of my family and friends, excellent medical care and treatment through the Medtronic Insulin pump with built in continuous glucose monitoring, I have been extremely happy and empowered in my diabetes management. I am personally using the insulin pump therapy for the last 18 years which helps me excel in all walks of life especially as an athlete, ” she said.